Patent Assignment
Reel/Frame 061809/0313
Assignment of Assignor's Interest
Recorded: 2022-11-17
Pages: 5
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Fusion Protein Inhibitors of KLK5
Application:
63/390,780 →